T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Tesla
TSLA
|
+$1.87B |
| 2 |
T-Mobile US
TMUS
|
+$1.53B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.43B |
| 4 |
Apple
AAPL
|
+$1.28B |
| 5 |
PepsiCo
PEP
|
+$1.1B |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
+$3.16B |
| 2 |
Amazon
AMZN
|
+$3.02B |
| 3 |
GE Aerospace
GE
|
+$2.2B |
| 4 |
Goldman Sachs
GS
|
+$1.76B |
| 5 |
Salesforce
CRM
|
+$1.43B |
Sector Composition
| 1 | Technology | 30.27% |
| 2 | Healthcare | 17.75% |
| 3 | Financials | 11.3% |
| 4 | Consumer Discretionary | 11.17% |
| 5 | Communication Services | 8.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1801
MYR Group
MYRG
$2.73B
| $956K | ﹤0.01% |
7,579
+2,897
| +62% | +$365K |
|
1802
CryoPort
CYRX
$433M
| $955K | ﹤0.01% |
39,781
+1,272
| +3% | +$30.5K |
|
1803
WaFd
WAFD
$2.46B
| $954K | ﹤0.01% |
31,657
+1,175
| +4% | +$35.4K |
|
|
B
1804
DELISTED
Barnes Group Inc.
B
| $952K | ﹤0.01% |
23,614
+892
| +4% | +$36K |
|
|
CIM
1805
Chimera Investment
CIM
$1.15B
| $949K | ﹤0.01% |
56,053
+6,127
| +12% | +$104K |
|
1806
Myriad Genetics
MYGN
$674M
| $947K | ﹤0.01% |
40,734
+1,163
| +3% | +$27K |
|
1807
Moelis & Co
MC
$5.54B
| $945K | ﹤0.01% |
24,578
+1,066
| +5% | +$41K |
|
1808
Compass Minerals
CMP
$753M
| $944K | ﹤0.01% |
27,514
+1,148
| +4% | +$39.4K |
|
1809
Methode Electronics
MEI
$287M
| $944K | ﹤0.01% |
21,502
+431
| +2% | +$18.9K |
|
1810
Provident Financial Services
PFS
$2.59B
| $941K | ﹤0.01% |
49,028
+1,296
| +3% | +$24.9K |
|
1811
Astrana Health
ASTH
$1.38B
| $941K | ﹤0.01% |
25,795
+968
| +4% | +$35.3K |
|
1812
Shake Shack
SHAK
$4.06B
| $938K | ﹤0.01% |
16,890
+651
| +4% | +$36.2K |
|
1813
Beam Therapeutics
BEAM
$2.08B
| $937K | ﹤0.01% |
30,569
+971
| +3% | +$29.8K |
|
|
EQC
1814
DELISTED
Equity Commonwealth
EQC
| $936K | ﹤0.01% |
45,151
-2,095,431
| -98% | -$43.4M |
|
1815
Trustmark
TRMK
$2.43B
| $934K | ﹤0.01% |
37,795
+1,130
| +3% | +$27.9K |
|
1816
Hanmi Financial
HAFC
$748M
| $932K | ﹤0.01% |
50,090
+7,312
| +17% | +$136K |
|
1817
NETSCOUT
NTCT
$1.8B
| $932K | ﹤0.01% |
32,508
+1,787
| +6% | +$51.2K |
|
|
NXGN
1818
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $927K | ﹤0.01% |
53,216
+548
| +1% | +$9.55K |
|
1819
Apogee Enterprises
APOG
$903M
| $926K | ﹤0.01% |
21,398
+2,695
| +14% | +$117K |
|
1820
Greif
GEF
$3.59B
| $925K | ﹤0.01% |
14,595
+463
| +3% | +$29.3K |
|
1821
Northwest Natural Holdings
NWN
$1.73B
| $917K | ﹤0.01% |
19,261
-1,874
| -9% | -$89.2K |
|
1822
BridgeBio Pharma
BBIO
$9.79B
| $916K | ﹤0.01% |
55,201
-11,321
| -17% | -$188K |
|
1823
Nu Skin
NUS
$596M
| $916K | ﹤0.01% |
23,286
-779
| -3% | -$30.6K |
|
1824
Cohen & Steers
CNS
$3.65B
| $914K | ﹤0.01% |
14,275
+434
| +3% | +$27.8K |
|
1825
Laureate Education
LAUR
$4.33B
| $913K | ﹤0.01% |
77,603
+2,032
| +3% | +$23.9K |
|